Product Description
Introducing Artesunate Injection IP - a scarce and trending antimalarial solution, engineered for first-rate efficacy in severe and cerebral malaria cases. This unmatchable lyophilized powder, containing artesunate 60 mg per vial, promises transcendent results as part of hospital-based, physician-supervised therapy. For intravenous or intramuscular use post-reconstitution, it's manufactured in a WHO-GMP certified facility and adheres to Indian Pharmacopoeia standards. Suitable for adults and children, it's a prescription-only, allopathic medicine. Each box includes one vial and solvent-use immediately after reconstitution. For optimal potency, store below 30C, protected from light.
Wide-Ranging Application Areas for Artesunate Injection IP
Artesunate Injection IP is specifically tailored for the treatment of severe malaria, including cerebral forms, in both adults and children. This drug is applied intravenously or intramuscularly in hospital settings to ensure safety and monitoring. The application surface is systemic, targeting the blood to eliminate the malaria parasite swiftly. As a plant derivative-based therapy, it is well-suited for anti-infective use across clinical environments requiring urgent and effective malarial intervention.
Sample Availability and Streamlined Delivery for Artesunate Injection IP
Artesunate Injection IP samples are available upon request to evaluate quality standards before purchase. Typically delivered within a reliable timeframe, the goods are shipped domestically across the Indian market, using trusted transport channels to ensure prompt and safe arrival. Our FOB port services from India facilitate secure export and distribution of high-quality pharmaceuticals, responding efficiently to urgent hospital and supplier requirements throughout the country.
FAQ's of Artesunate Injection IP:
Q: How should Artesunate Injection IP be administered?
A: Artesunate Injection IP must be reconstituted with the supplied sterile water and administered intravenously or intramuscularly under physician supervision in a hospital setting.
Q: What is the main therapeutic benefit of Artesunate Injection IP?
A: It provides rapid and effective antimalarial therapy, especially for severe and cerebral malaria, ensuring swift parasite clearance and improved patient outcomes.
Q: When should the injection be used after reconstitution?
A: Artesunate Injection IP should be used immediately after reconstitution to maintain its potency and effectiveness.
Q: Where is Artesunate Injection IP manufactured?
A: This product is manufactured in India, in a WHO-GMP certified facility that adheres to stringent Indian Pharmacopoeia standards.
Q: What precautions should be taken while using Artesunate Injection IP?
A: The injection is for hospital use only. Patients should be closely monitored for any adverse reactions or allergies, especially if hypersensitive to artesunate or artemisinin derivatives.
Send Inquiry
Send Inquiry
Send SMS
Call Me Free
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese